Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

29.3 Introduction to the Small and Large Intestines

Pharmacology for Nurses29.3 Introduction to the Small and Large Intestines

Learning Outcomes

By the end of this section, you should be able to:

  • 29.3.1 Describe the structure and function of the small and large intestines.
  • 29.3.2 Discuss common conditions that affect the small and large intestines.

Small and Large Intestines

The largest GI organ is the small intestine (Figure 29.6). The duodenum, jejunum, ileum, and ileocecal valve comprise the almost 20 feet of the small intestine. The primary functions of the small intestine are absorption and digestion; the small intestine is responsible for 90%–95% of nutrient absorption. The muscles of the small intestine further mix the chyme with digestive fluids for continued breakdown. The small intestine receives digestive juices from the liver, gallbladder, and pancreas. Bile acids from the liver and gallbladder enter the small intestine and break down fat for absorption in the small intestine. The pancreatic enzymes lipase, protease, and amylase travel through the pancreatic duct to the small intestine to facilitate digestion. Lipase, together with bile salts, breaks down fats and aids absorption of fat-soluble vitamins (A, D, E, K). Poor fat absorption may result in steatorrhea (fatty bowel movements). Protease breaks down protein for absorption. Amylase is released from the pancreas into the proximal small intestine to break down and absorb carbohydrates.

A diagram shows the placement of the parts of the small intestine. The duodenum is first and connects to the stomach. Next is the jejunum, followed by the ileum. The small intestines are surrounded by the large intestine, which ends at the rectum.
Figure 29.6 The three main regions of the small intestine are the duodenum, jejunum, and ileum. (credit: modification of work from Anatomy and Physiology 2e. attribution: Copyright Rice University, OpenStax, under CC BY 4.0 license)

Unique to the small intestine are tiny fingerlike projections called villi that line the walls of the small intestine. The villi protrude into the lumen to absorb water and nutrients into the circulatory system. The highly vascular villi line the entire small intestine to accomplish most of the digestion and absorption processes as peristalsis continues to move nutrients and digestive waste along the alimentary canal. The blood capillaries absorb carbohydrates and proteins. The lymph capillaries, also called lacteals, absorb fats. Disorders affecting the intestinal villi of the small intestine may result in malabsorption or nutritional disorders.

The large intestine, also known as the colon, receives waste products from the small intestine. Water is further absorbed from the waste products in the large intestine and forms stool. Peristaltic movements push stool toward the rectum. Under expected conditions, when waste products reach the rectum, most of the water has been reabsorbed into the body, leaving solid stool for evacuation from the body. The large intestine receives unabsorbed and undigested food material (waste products), absorbs water and electrolytes, and forms feces. The large intestine maintains over 500 species of bacteria that promote fermentation of indigestible material in the colon. The bacteria in the large intestine are responsible for absorbing vitamin K and B vitamins, including biotin (Thursby & Juge, 2017).

Irritable bowel syndrome (IBS) is a common disorder affecting the intestine. The symptoms of IBS range from mild to severe and vary from person to person. Symptoms may include bloating, gas, abdominal pain or discomfort, abdominal spasms, cramping, and constipation or diarrhea (or both). Because people experience varying types of symptoms, IBS is further categorized as IBS-C (constipation), IBS-D (diarrhea), IBS-M (mixed symptoms of diarrhea and constipation), and IBS-U (unsubtyped, with varying inconsistent symptoms). Although IBS is a chronic condition, most people with IBS can manage their disease with lifestyle changes such as consistently eating healthy, balanced meals; staying hydrated; and reducing stress.

Table 29.2 lists common GI conditions, associated general manifestations, and drugs commonly used to treat these conditions. Table 29.3 presents common actions of digestive enzymes.

GI Conditions Manifestations Common Drugs Used to Treat GI Conditions
  • Food or medication allergies
  • Adverse reaction to medications
  • Frequent use of nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Food poisoning
  • Intestinal infections
  • Esophageal strictures
  • Celiac disease
  • Crohn’s disease
  • Irritable bowel syndrome
  • Cholecystitis/cholelithiasis
  • Ulcers (peptic ulcer disease)
  • Gastritis
  • GERD
  • Pancreatitis
  • Liver disease
  • Polyps
  • Hemorrhoids
  • Cancer
  • Bloating
  • Belching
  • Nausea
  • Vomiting
  • Dyspepsia
  • Heartburn
  • Dysphagia
  • Abdominal pain
  • Diarrhea/constipation
  • Bleeding
  • Flatus
  • Visceral pain
  • Antiemetics: phenothiazines/dopamine antagonists, prokinetic agents, antihistamines, serotonin receptor antagonists, neurokinin-1 (substance P) receptor antagonists, anticholinergics, cannabinoids
  • Antidiarrheals: nonspecific drugs (e.g., opioids) and specific drugs (e.g., bismuth subsalicylate, bulk-forming agents)
  • Laxatives: bulk-forming agents (e.g., psyllium), surfactants (e.g., docusate sodium), stimulants (e.g., bisacodyl), osmotics (e.g., magnesium citrate, lactulose), lubricants (e.g., mineral oil)
  • Medications for IBS: lubiprostone for IBS-C and alosetron for IBS-D
  • Antacids (aluminum, magnesium, calcium, and sodium compounds)
  • Histamine type-2 receptor antagonists (e.g., famotidine, cimetidine)
  • Proton pump inhibitors (e.g., esomeprazole, omeprazole)
  • Pepsin inhibitors/mucosal protectants (e.g., sucralfate)
  • Prostaglandin-E analogs (e.g., misoprostol)
  • Antibiotics (e.g., amoxicillin, clarithromycin, metronidazole, tetracycline)
Table 29.2 Common Gastrointestinal Conditions
Active Site Enzyme Effect on Nutrients
Mouth Salivary amylase Breaks down starches into disaccharides
Stomach Pepsin Breaks down proteins into large peptides
Pancreas Amylase Continues the breakdown of starches
Pancreas Chymotrypsin, trypsin Continue the breakdown of proteins
Pancreas Lipase Breaks down fats into fatty acids and glycerol
Small intestine Maltase, sucrase, lactase Break down disaccharides into monosaccharides
Small intestine Peptidase Breaks down dipeptides into amino acids
Table 29.3 Common Actions of Digestive Enzymes

Clinical Tip

Assess for Gastrointestinal Health Practices

When taking a client’s health history, nurses should ask about:

  • Dietary practices: food preparation, food shopping and accessibility, healthy and unhealthy food choices, cultural or religious food preferences, meal timing, food allergies or intolerances
  • Nutritional supplements: vitamins, minerals, herbal or natural supplements, need for nutritional counseling
  • Oral health: dental history, tooth or gum disease, oral mucosal integrity
  • Appetite: recent changes
  • Preventive health: hydration habits, exercise habits, colonoscopy history
  • Bowel movements: changes in patterns
  • Weight: recent unintended weight gain or loss
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.